| Mr David Carl Solseng, OD | |
|
402 E 3rd St, Suite #1, Ada, MN 56510 | |
| (218) 784-4091 | |
| (218) 784-4092 |
| Full Name | Mr David Carl Solseng |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 26 Years |
| Location | 402 E 3rd St, Ada, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104915990 | NPI | - | NPPES |
| 2200530 | Other | MEDICA | |
| 234001 | Other | ND | BLUE SHEILD OF ND |
| 314004100 | Medicaid | MN | |
| 09G48VA | Other | MN | BC BS MN |
| 2200530 | Other | MEDICA CHOICE SELECT | |
| 09G48VA | Other | MN | MA-BLUE PLUS OF MN |
| 800570 | Other | VISION SERVICES INC | |
| 2200530 | Other | MEDICA-MA | |
| 2200530 | Other | MEDICA PRIMARY | |
| 60081 | Other | ND | ND MA |
| 126057 | Other | U CARE MINNESOTA | |
| 639111042770 | Other | PREFERRED ONE | |
| 314004100 | Other | MN | DEPT OF HUMAN SERVICES |
| 09G48VA | Other | MN | BLUE PLUS OF MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 570 (North Dakota) | Secondary |
| 152W00000X | Optometrist | 2705 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Vision Clinic Ltd | 0244299287 | 7 |
| Valley Vision Clinic Ltd | 0244299287 | 7 |
News Archive
Nearly two dozen of the world's leading neuroscientists will gather in Switzerland next month to share their latest findings on the mysteries of how the brain processes information and makes decisions.
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, home health, hospice care and assisted living companies, today reported record results for the second quarter of 2010.
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.
In a recent issue of Cancer Research, Daniel J. Powell, Jr., PhD, a research assistant professor of Pathology and Laboratory Medicine and Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, showed for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice.
› Verified 2 days ago
| Provider Name | Valley Vision Clinic Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619168267 PECOS PAC ID: 0244299287 Enrollment ID: O20041006000529 |
News Archive
Nearly two dozen of the world's leading neuroscientists will gather in Switzerland next month to share their latest findings on the mysteries of how the brain processes information and makes decisions.
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, home health, hospice care and assisted living companies, today reported record results for the second quarter of 2010.
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.
In a recent issue of Cancer Research, Daniel J. Powell, Jr., PhD, a research assistant professor of Pathology and Laboratory Medicine and Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, showed for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr David Carl Solseng, OD 2200 S Washington St, Grand Forks, ND 58201-6346 Ph: (701) 775-3135 | Mr David Carl Solseng, OD 402 E 3rd St, Suite #1, Ada, MN 56510 Ph: (218) 784-4091 |
News Archive
Nearly two dozen of the world's leading neuroscientists will gather in Switzerland next month to share their latest findings on the mysteries of how the brain processes information and makes decisions.
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, home health, hospice care and assisted living companies, today reported record results for the second quarter of 2010.
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.
In a recent issue of Cancer Research, Daniel J. Powell, Jr., PhD, a research assistant professor of Pathology and Laboratory Medicine and Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, showed for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice.
› Verified 2 days ago